Approval · Notice of Compliance 5777 · 1994
ERYMAX: Notice of Compliance 5777
Issued July 29, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5777
- Date
- July 29, 1994
- Company
- Allergan Herbert Skin Care Division Of Allergan Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Topical anti-acne
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERYMAX | 02115549 | — |
Medicinal ingredients
- ERYTHROMYCIN 2 PER
- ALCOHOL ANHYDROUS 66 PER